E24.0
Pituitary-dependent Cushing's disease
Clinical Classification Guidelines
Inclusion Terms
- Overproduction of pituitary ACTH
- Pituitary-dependent hypercorticalism
Medical Intelligence & Overview
Pituitary-dependent Cushing's disease, classified under ICD-10 code E24.0, is a condition characterized by an excessive production of cortisol due to an overactive pituitary gland. This overproduction is primarily caused by a benign tumor in the pituitary, leading to increased secretion of adrenocorticotropic hormone (ACTH). Elevated ACTH levels stimulate the adrenal glands to produce more cortisol than necessary, resulting in a range of health issues. This form of hypercorticalism is distinct from other causes of Cushing's syndrome, such as adrenal tumors or external sources of cortisol, and requires specific diagnosis and management.
Causes & Symptoms
Clinical Causes: Presence of a benign tumor (adenoma) in the pituitary gland Abnormal regulation of ACTH production by the pituitary Genetic factors that predispose to pituitary tumor development Rare cases where multiple endocrine neoplasia syndromes are involved
Key Symptoms: Weight gain, particularly around the abdomen and face (moon face) Purple stretch marks on the abdomen, thighs, and breasts Facial rounding and increased facial hair in women Muscle weakness and thinning of the skin High blood pressure (hypertension) Elevated blood sugar levels, potentially leading to diabetes Bone loss and increased risk of fractures Mood changes, such as depression or anxiety Fatigue and muscle aches Menstrual irregularities in women
Diagnostic & Treatment
Diagnosis Path: Diagnosing pituitary-dependent Cushing's disease involves a combination of clinical assessment and laboratory tests. Key diagnostic steps include: - **Measurement of cortisol levels** in blood, urine, or saliva, often looking for elevated levels. - **Dexamethasone suppression tests** to assess how cortisol levels respond to suppression attempts. - **Measurement of ACTH levels** to determine if the overproduction is linked to the pituitary. - **Imaging studies**, such as MRI scans of the pituitary gland, to identify tumors. - **Additional tests** may include petrosal sinus sampling to distinguish pituitary sources from ectopic ACTH production. Proper diagnosis is crucial for determining the most appropriate treatment approach.
Treatment Protocols: Treatment options focus on reducing cortisol levels and addressing the underlying pituitary tumor. Common approaches include: - **Surgical removal of the pituitary tumor (transsphenoidal surgery)**, which is often the first-line treatment. - **Radiation therapy** to the pituitary gland if surgery is unsuccessful or not feasible. - **Medications** that inhibit cortisol production or block its effects, such as ketoconazole, metyrapone, or mitotane. - **Management of associated health issues**, including controlling blood pressure, blood sugar, and bone health. - **Long-term monitoring** for potential tumor recurrence or hormonal imbalances. Collaborating with specialists like endocrinologists is essential to develop a personalized treatment plan.
Clinical Advice & FAQs
Billing Guidance
Is E24.0 a billable ICD-10 code?
Yes, E24.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E24.0?
Clinical documentation must specify the nature of Pituitary-dependent Cushing's disease and any associated comorbidities for accurate reporting.
Cite this Clinical Reference